How do you see the future of the cancer genomics field evolving? - Stefan Pfister

Описание: Well, on the one hand side, I think much of clinical cancer genomics has now become kind of a part of the standard of care in some indications, especially when it comes to very rare tumors, where we don't really have a lot of established second- and third-line treatment options.
But at the same time, we also realize that it's not solving everything, so I guess we also have to think more about functionally understanding tumor genomes, adding other levels of omics, probably also adding functional testing more and more to the patient individual readouts, so there's still a lot to do in front of us.